open access

Vol 29, No 1 (2022)
Letter to the Editor
Submitted: 2021-09-10
Accepted: 2021-11-14
Published online: 2021-11-19
Get Citation

Myocarditis: A complication of COVID-19 and long-COVID-19 syndrome as a serious threat in modern cardiology

Lukasz Szarpak123, Michal Pruc3, Krzysztof J. Filipiak1, Julia Popieluch4, Andrzej Bielski35, Milosz J. Jaguszewski6, Natasza Gilis-Malinowska6, Francesco Chirico78, Zubaid Rafique9, Frank W. Peacock9
Pubmed: 34811716
Cardiol J 2022;29(1):178-179.
  1. Institute of Outcomes Research, Maria Sklodowska-Curie Medical Academy, Warsaw, Poland
  2. Maria Sklodowska-Curie Bialystok Oncology Center, Bialystok, Poland
  3. Research Unit, Polish Society of Disaster Medicine, Warsaw, Poland
  4. Students Research Club, Maria Sklodowska-Curie Medical Academy, Warsaw, Poland
  5. Polonia University, Czestochowa, Poland
  6. 1st Chair and Department of Cardiology, Medical University of Gdansk, Poland
  7. Post-graduate School of Occupational Health, Università Cattolica del Sacro Cuore, Rome, Italy
  8. Health Service Department, Italian State Police, Milan, Italy
  9. Henry JN Taub Department of Emergency Medicine, Baylor College of Medicine, Houston, TX, United States

open access

Vol 29, No 1 (2022)
Letters to the Editor — COVID-19
Submitted: 2021-09-10
Accepted: 2021-11-14
Published online: 2021-11-19


Not available


Not available
Get Citation
About this article

Myocarditis: A complication of COVID-19 and long-COVID-19 syndrome as a serious threat in modern cardiology


Cardiology Journal


Vol 29, No 1 (2022)

Article type

Letter to the Editor



Published online


Page views


Article views/downloads






Bibliographic record

Cardiol J 2022;29(1):178-179.


Lukasz Szarpak
Michal Pruc
Krzysztof J. Filipiak
Julia Popieluch
Andrzej Bielski
Milosz J. Jaguszewski
Natasza Gilis-Malinowska
Francesco Chirico
Zubaid Rafique
Frank W. Peacock

References (10)
  1. Pollack A, Kontorovich AR, Fuster V, et al. Viral myocarditis--diagnosis, treatment options, and current controversies. Nat Rev Cardiol. 2015; 12(11): 670–680.
  2. Robak O, Dudek M, Ladny JR, et al. Cardiac tamponade as a cause of COVID-19. Cardiol J. 2020; 27(6): 900–901.
  3. Ruan Q, Yang K, Wang W, et al. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med. 2020; 46(6): 1294–1297.
  4. Puntmann VO, Carerj ML, Wieters I, et al. Outcomes of cardiovascular magnetic resonance imaging in patients recently recovered from coronavirus disease 2019 (COVID-19). JAMA Cardiol. 2020; 5(11): 1265–1273.
  5. Eiros R, Barreiro-Perez M, Martin-Garcia A, et al. Pericarditis and myocarditis long after SARS-CoV-2 infection: a cross-sectional descriptive study in health-care workers. medRxiv. 2020.
  6. Singer ME, Taub IB, Kaelber DC. Risk of Myocarditis from COVID-19 Infection in People Under Age 20: A Population-Based Analysis. medRxiv. 2021.
  7. Boehmer TK, Kompaniyets L, Lavery AM, et al. Association Between COVID-19 and Myocarditis Using Hospital-Based Administrative Data - United States, March 2020-January 2021. MMWR Morb Mortal Wkly Rep. 2021; 70(35): 1228–1232.
  8. Antonelli M, Penfold RS, Merino J, et al. Risk factors and disease profile of post-vaccination SARS-CoV-2 infection in UK users of the COVID Symptom Study app: a prospective, community-based, nested, case-control study. Lancet Infect Dis. 2021 [Epub ahead of print].
  9. Diaz GA, Parsons GT, Gering SK, et al. Myocarditis and pericarditis after vaccination for COVID-19. JAMA. 2021; 326(12): 1210–1212.
  10. Delahoy MJ, Ujamaa D, Whitaker M, et al. Hospitalizations Associated with COVID-19 Among Children and Adolescents - COVID-NET, 14 States, March 1, 2020-August 14, 2021. MMWR Morb Mortal Wkly Rep. 2021; 70(36): 1255–1260.


Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By VM Media Group sp. z o.o., Grupa Via Medica, ul. Świętokrzyska 73, 80–180 Gdańsk, Poland
tel.:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: